Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Transfusion and Apheresis ScienceReferences
Shepherd J et al. Prevention of coronary heart disease with pravastatin in men with hypercholestérolemia. N Engl J Med 1995;333:1301–1307
Smith GD, Song F, Sheldon TA. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 1993;306:1367–1373
Scandinavan simvastatin survival study group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the scandinavian simvastatin survival study (4S). Lancet 1994;344:1383–1389
Aengevaeren WRM, Kroon AA, Stalenhoef AFH, Uijen GJH, van de Werf T. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary heart disease. JACC 1996;28:1696–1704
Dairou F, Assogba U, Bruckert E, De Gennes JL, Truffert J. Efficacité biologique des LDL aphérèses dans les hypercholestérolémies majeures. Ann Med Interne 1994;145(5):328–332
Dairou F, Rottembourg G, De Gennes JL, Assogba U, Bruckert E, Jacobs C, Truffert J. Comparaison des traitements des formes sévères d'hypercholestérolémie familiale par échange plasmatique total et épuration sélective des lipoproteines de basse densité (LDLaphérèse). Presse médicale 1988;33(17):1679–1682
Bosch T, Schmidt B, Blumenstein M, Gurland HJ. Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood. Arti Org 1993;17:640–652
Klein JM, Drobinski G, Bruckert E, Dairou F, Thomas D, De Gennes JL, Grogosgeat Y. Results of serial coronary angiography in patients with homozygous familial hypercholesterolemia. European Heart J 1988;9:1067–1073
Jaudon M-C, Assogba U, Bourely B, Dairou F, Bruckert E, Delattre J. Selenium deficiency in hypercholesterolemic patients treated by LDL apheresis. Lancet 1994;343:1160
Assogba U, Lepage S, Bruckert E, Bonnefont-Rousselot D, Dairou F, DE Gennes JL, Delattre J. Blood antioxidants (vitamin E and beta-carotene) in long-term low density lipoprotein apheresis. Clin Chim Acta 1995;235:147–157
Persson-Moschos M, Bonnefont-Rousselot D, Assogba U, Bruckert E, Jaudon MC, Delattre J, Akesson B. Preferential depletion of selenoprotein P in hypercholesterolemic patients treated by LDL-apheresis. Clin Chim Acta 1995;204:209–212
Dejager S, Bruckert E, Chapman MJ. Diminished oxidative resistance of low density lipoprotein subspecies in combined hyperlipidemia. J Lipid Res 1993;34:295–308
Faucher C, Albert C, Beaufils H, Jouanneau C, Dupouet L. Remission of a refractory nephrotic syndrome after low-density lipoprotein apheresis based on dextrant sulphate adsorption. Nephrol Dial Transplant 1997;12:1037–1039
